Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749305 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness of Metabolic and Bariatric Surgery With PROMs
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 11,146
- Enrollment target
NCT02749305: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02749305 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 11,146 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (694% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02749305, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,146 participants
- Enrollment target
Study Summary
This long-term, nationwide observational data collection repository will obtain patient-reported outcomes from metabolic and bariatric surgery patients. The data will be used in conjunction with clinical outcomes to determine quality, safety, and comparative effectiveness of various metabolic and bariatric procedures.
Primary Outcome
patients will be asked to complete the PROMIS (Patient-Reported Outcomes Measurement Information System) 10 survey
Interventions
- OTHER Collection of patient-reported outcome measures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,146 participants |
| Start Date | 2016-03 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
What the finished NCT02749305 record still lists
NCT02749305 is an interventional study that assigns participants to a tested intervention. Its 11,146 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (694% higher).
The record links to 0 conditions, and to 1 intervention - of which Collection of patient-reported outcome measures is the first listed.
NCT02749305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02749305 about?
NCT02749305 is a clinical study titled "Comparative Effectiveness of Metabolic and Bariatric Surgery With PROMs". This long-term, nationwide observational data collection repository will obtain patient-reported outcomes from metabolic and bariatric surgery patients. The data will be used in conjunction with clinical outcomes to determine quality, safety, and comparative effectiveness of various metabolic and ba...
What is the current status of trial NCT02749305?
This trial is currently completed. It is a NA study. The enrollment target is 11,146 participants. The study started on 2016-03. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT02749305?
The interventions under investigation include: Collection of patient-reported outcome measures (OTHER).
Who is sponsoring clinical trial NCT02749305?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02749305's enrollment target sits among peer trials
11,146 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- NCT07181109 · 11,000 participants · Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- NCT06677060 · 11,300 participants · Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia